Veterinary CRO Market by Service Type (Clinical Trials, Toxicology, Market Authorization & Regulatory Support and Others), Application (Dogs, Cats, and Others), End User (Oncology, Infectious Diseases, Neurology and Others): Global Opportunity Analysis and Industry Forecast, 2019 - 2026

LI_196265
Pages: 181
December 2019
Total Views:1441
Region : Global
Allied Market Research
Market Research Report

Select a License

Single User License

USD 5370

Corporate User License

USD 8995

Details

The global veterinary CRO market was valued at USD 485.5 million in 2018, and is expected to reach USD 894.7 million by 2026, registering a CAGR of 7.9% from 2019 to 2026.

Contract research organizations (CROs) are companies that aid in conducting research for a sponsor company. Moreover, veterinary CROs are companies, which are specialized in in-vivo studies that involve companion animals. Sponsor companies seek provision from veterinary CROs to support research and development programs for biopharmaceutical industries. Furthermore, different types of services are provided by veterinary CROs such as clinical trials, toxicology, and market authorization & regulatory support. These services are utilized by veterinary medicine manufacturers to test the safety and efficacy of veterinary drugs, which are used in different indications such as oncology, neurology, and infectious diseases.

The factors that boost the growth of the veterinary CRO market include surge in ownership of companion animals and rise in animal health expenditure. Furthermore, other factors such as increase in prevalence of various diseases among companion animal acts as a major factor that contributes toward the growth of the market. However, lack of standardization in veterinary CROs is a factor that restrains the growth of the market. Conversely, surge in awareness related to animal healthcare across the globe is expected to provide lucrative opportunities in the market during the forecast period.

The veterinary CRO market is segmented into service type, animal type, indication, and region. On the basis of service type, the market is divided into clinical trials, toxicology, market authorization & regulatory support, and others. By animal type, the market is classified into dogs, cats, and others. Depending on indication, it is categorized into oncology, infectious disease, neurology, and others. Region wise, it is analyzed across North America (U.S, Canada, and Mexico) and Europe (Germany, France, Italy, Spain, UK and rest of Europe), Asia-Pacific (Japan, China, Australia, rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

This report entails a detailed quantitative analysis along with the current global veterinary CRO market trends from 2019 to 2026 to identify the prevailing opportunities along with the strategic assessment.

The market size and estimations are based on a comprehensive analysis of key developments in the industry.

A qualitative analysis based on innovative service types facilitates strategic business planning.

The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Key Market Segments

By Service Type

o Clinical Trials

o Toxicology

o Market Authorization & Regulatory Support

o Others

By Animal Type

o Dogs

o Cats

o Others

By Indication

o Oncology

o Infectious Disease

o Neurology

o Others

By Region

o North America

o U.S.

o Canada

o Mexico

o Europe

o Germany

o France

o UK

o Italy

o Spain

o Rest of Europe

o Asia-Pacific

o Japan

o China

o Australia

o Rest of Asia-Pacific

o LAMEA

o Brazil

o Saudi Arabia

o South Africa

o Rest Of LAMEA

List of key players profiled in the report:

Charles River Laboratories, Inc.

Clinvet

KLIFOVET AG

Lohlein & Wolf Vet Research

Oncovet Clinical Research

ONDAX Scientific

Triveritas

Veterinary Research Management (VRM) Ltd

VetPharm, Inc.

VETSPIN SRL

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)

AlcheraBio

Likarda

Scope

Chapter 1: Introduction

1.1. Report Description

1.2. Key Benefits For Stakeholders

1.3. Key Market Segments

1.3.1. List of Key Players Profiled In The Report

1.4. Research Methodology

1.4.1. Secondary Research

1.4.2. Primary Research

1.4.3. Analyst Tools And Models

Chapter 2: Executive Summary

2.1. Key Findings of The Study

2.1.1. Top Impacting Factors

2.1.2. Top Investment Pockets

2.2. Cxo Perspective

Chapter 3: Market Overview

3.1. Market Definition And Scope

3.2. Porter'S Five Forces Analysis

3.2.1. Bargaining Power of Buyers

3.2.2. Bargaining Power of Suppliers

3.2.3. Thereat of New Entrants

3.2.4. Threat of Substitutes

3.2.5. Intensity of Competitive Rivalry

3.3. Market Dynamics

3.3.1. Drivers

3.3.1.1. Surge In Ownership of Companion Animals

3.3.1.2. Rise In Animal Health Expenditure

3.3.1.3. Increase In Prevalence of Various Diseases Among Companion Animals

3.3.2. Restraint

3.3.2.1. Lack of Standardization In Veterinary Cros

3.3.3. Opportunity

3.3.3.1. Surge In Awareness Related To Animal Healthcare

3.3.4. Impact Analysis

Chapter 4: Veterinary Cro Market, By Service Type

4.1. Overview

4.1.1. Market Size And Forecast

4.2. Clinical Trials

4.2.1. Key Market Trends And Growth Opportunities

4.2.2. Market Size And Forecast, By Region

4.2.3. Market Analysis By Country

4.3. Toxicology

4.3.1. Key Market Trends And Growth Opportunities

4.3.2. Market Size And Forecast, By Region

4.3.3. Market Analysis By Country

4.4. Market Authorization And Regulatory Support

4.4.1. Key Market Trends And Growth Opportunities

4.4.2. Market Size And Forecast, By Region

4.4.3. Market Analysis By Country

4.5. Others

4.5.1. Key Market Trends And Growth Opportunities

4.5.2. Market Size And Forecast, By Region

4.5.3. Market Analysis By Country

Chapter 5: Veterinary Cro Market, By Animal Type

5.1. Overview

5.1.1. Market Size And Forecast

5.2. Dogs

5.2.1. Market Size And Forecast, By Region

5.2.2. Market Analysis By Country

5.3. Cats

5.3.1. Market Size And Forecast, By Region

5.3.2. Market Analysis By Country

5.4. Others

5.4.1. Market Size And Forecast, By Region

5.4.2. Market Analysis By Country

Chapter 6: Veterinary Cro Market, By Indication

6.1. Overview

6.1.1. Market Size And Forecast

6.2. Oncology

6.2.1. Market Size And Forecast, By Region

6.2.2. Market Analysis By Country

6.3. Infectious Disease

6.3.1. Market Size And Forecast, By Region

6.3.2. Market Analysis By Country

6.4. Neurology

6.4.1. Market Size And Forecast, By Region

6.4.2. Market Analysis By Country

6.5. Others

6.5.1. Market Size And Forecast, By Region

6.5.2. Market Analysis By Country

Chapter 7: Veterinary Cro Market, By Region

7.1. Overview

7.1.1. Market Size And Forecast

7.2. North America

7.2.1. Key Market Trends And Opportunities

7.2.2. Market Analysis By Country

7.2.2.1. U.S.

7.2.2.1.1. U.S. Market Size And Forecast, By Service Type

7.2.2.1.2. U.S. Market Size And Forecast, By Animal Type

7.2.2.1.3. U.S. Market Size And Forecast, By Indication

7.2.2.2. Canada

7.2.2.2.1. Canada Market Size And Forecast, By Service Type

7.2.2.2.2. Canada Market Size And Forecast, By Animal Type

7.2.2.2.3. Canada Market Size And Forecast, By Indication

7.2.2.3. Mexico

7.2.2.3.1. Mexico Market Size And Forecast, By Service Type

7.2.2.3.2. Mexico Market Size And Forecast, By Animal Type

7.2.2.3.3. Mexico Market Size And Forecast, By Indication

7.2.3. North America Market Size And Forecast, By Service Type

7.2.4. North America Market Size And Forecast, By Animal Type

7.2.5. North America Market Size And Forecast, By Indication

7.3. Europe

7.3.1. Key Market Trends And Opportunities

7.3.2. Market Analysis By Country

7.3.2.1. Germany

7.3.2.1.1. Germany Market Size And Forecast, By Service Type

7.3.2.1.2. Germany Market Size And Forecast, By Animal Type

7.3.2.1.3. Germany Market Size And Forecast, By Indication

7.3.2.2. France

7.3.2.2.1. France Market Size And Forecast, By Service Type

7.3.2.2.2. France Market Size And Forecast, By Animal Type

7.3.2.2.3. France Market Size And Forecast, By Indication

7.3.2.3. Uk

7.3.2.3.1. Uk Market Size And Forecast, By Service Type

7.3.2.3.2. Uk Market Size And Forecast, By Animal Type

7.3.2.3.3. Uk Market Size And Forecast, By Indication

7.3.2.4. Italy

7.3.2.4.1. Italy Market Size And Forecast, By Service Type

7.3.2.4.2. Italy Market Size And Forecast, By Animal Type

7.3.2.4.3. Italy Market Size And Forecast, By Indication

7.3.2.5. Spain

7.3.2.5.1. Spain Market Size And Forecast, By Service Type

7.3.2.5.2. Spain Market Size And Forecast, By Animal Type

7.3.2.5.3. Spain Market Size And Forecast, By Indication

7.3.2.6. Rest of Europe

7.3.2.6.1. Rest of Europe Market Size And Forecast, By Service Type

7.3.2.6.2. Rest of Europe Market Size And Forecast, By Animal Type

7.3.2.6.3. Rest of Europe Market Size And Forecast, By Indication

7.3.3. Europe Market Size And Forecast, By Service Type

7.3.4. Europe Market Size And Forecast, By Animal Type

7.3.5. Europe Market Size And Forecast, By Indication

7.4. Asia-Pacific

7.4.1. Key Market Trends And Opportunities

7.4.2. Market Analysis By Country

7.4.2.1. Japan

7.4.2.1.1. Japan Market Size And Forecast, By Service Type

7.4.2.1.2. Japan Market Size And Forecast, By Animal Type

7.4.2.1.3. Japan Market Size And Forecast, By Indication

7.4.2.2. China

7.4.2.2.1. China Market Size And Forecast, By Service Type

7.4.2.2.2. China Market Size And Forecast, By Animal Type

7.4.2.2.3. China Market Size And Forecast, By Indication

7.4.2.3. Australia

7.4.2.3.1. Australia Market Size And Forecast, By Service Type

7.4.2.3.2. Australia Market Size And Forecast, By Animal Type

7.4.2.3.3. Australia Market Size And Forecast, By Indication

7.4.2.4. Rest of Asia-Pacific

7.4.2.4.1. Rest of Asia-Pacific Market Size And Forecast, By Service Type

7.4.2.4.2. Rest of Asia-Pacific Market Size And Forecast, By Animal Type

7.4.2.4.3. Rest of Asia-Pacific Market Size And Forecast, By Indication

7.4.3. Asia-Pacific Market Size And Forecast, By Service Type

7.4.4. Asia-Pacific Market Size And Forecast, By Animal Type

7.4.5. Asia-Pacific Market Size And Forecast, By Indication

7.5. Lamea

7.5.1. Key Market Trends And Opportunities

7.5.2. Market Analysis By Country

7.5.2.1. Brazil

7.5.2.1.1. Brazil Market Size And Forecast, By Service Type

7.5.2.1.2. Brazil Market Size And Forecast, By Animal Type

7.5.2.1.3. Brazil Market Size And Forecast, By Indication

7.5.2.2. South Africa

7.5.2.2.1. South Africa Market Size And Forecast, By Service Type

7.5.2.2.2. South Africa Market Size And Forecast, By Animal Type

7.5.2.2.3. South Africa Market Size And Forecast, By Indication

7.5.2.3. Saudi Arabia

7.5.2.3.1. Saudi Arabia Market Size And Forecast, By Service Type

7.5.2.3.2. Saudi Arabia Market Size And Forecast, By Animal Type

7.5.2.3.3. Saudi Arabia Market Size And Forecast, By Indication

7.5.2.4. Rest of Lamea

7.5.2.4.1. Rest of Lamea Market Size And Forecast, By Service Type

7.5.2.4.2. Rest of Lamea Market Size And Forecast, By Animal Type

7.5.2.4.3. Rest of Lamea Market Size And Forecast, By Indication

7.5.3. Lamea Market Size And Forecast, By Service Type

7.5.4. Lamea Market Size And Forecast, By Animal Type

7.5.5. Lamea Market Size And Forecast, By Indication

Chapter 8: Competitive Landscape

8.1. Introduction

8.1.1. Market Player Positioning, 2018

8.2. Top Winning Strategies And Key Developments

8.3. Competitive Dashboard

8.4. Competitive Heatmap

Chapter 9: Company Profiles

9.1. Charles River Laboratories, Inc.

9.1.1. Company Overview

9.1.2. Company Snapshot

9.1.3. Operating Business Segments

9.1.4. Product Portfolio

9.1.5. Business Performance

9.1.6. Key Strategic Moves And Developments

9.2. Clinvet

9.2.1. Company Overview

9.2.2. Company Snapshot

9.2.3. Operating Business Segments

9.2.4. Product Portfolio

9.2.5. Key Strategic Moves And Developments

9.3. Klifovet Ag

9.3.1. Company Overview

9.3.2. Company Snapshot

9.3.3. Operating Business Segments

9.3.4. Product Portfolio

9.4. Lohlein & Wolf Vet Research

9.4.1. Company Overview

9.4.2. Company Snapshot

9.4.3. Operating Business Segments

9.4.4. Product Portfolio

9.4.5. Key Strategic Moves And Developments

9.5. Oncovet Clinical Research

9.5.1. Company Overview

9.5.2. Company Snapshot

9.5.3. Operating Business Segments

9.5.4. Product Portfolio

9.6. Ondax Scientific

9.6.1. Company Overview

9.6.2. Company Snapshot

9.6.3. Operating Business Segments

9.6.4. Product Portfolio

9.6.5. Key Strategic Moves And Developments

9.7. Triveritas

9.7.1. Company Overview

9.7.2. Company Snapshot

9.7.3. Operating Business Segments

9.7.4. Product Portfolio

9.8. Veterinary Research Management (Vrm) Ltd

9.8.1. Company Overview

9.8.2. Company Snapshot

9.8.3. Operating Business Segments

9.8.4. Product Portfolio

9.9. Vetpharm, Inc.

9.9.1. Company Overview

9.9.2. Company Snapshot

9.9.3. Operating Business Segments

9.9.4. Product Portfolio

9.10. Vetspin Srl

9.10.1. Company Overview

9.10.2. Company Snapshot

9.10.3. Operating Business Segments

9.10.4. Product Portfolio

List Of Figure

List of Figures

Figure 01. Top Impacting Factors

Figure 02. Top Investment Pockets

Figure 03. North America And Europe Veterinary Cro Market Segmentation

Figure 04. Low Bargaining Power of Buyers

Figure 05. Low Bargaining Power of Suppliers

Figure 06. Low Threat of New Entrants

Figure 08. Moderate Competitive Rivalry

Figure 09. U.S. Pet Industry Expenditure, 2007-2017 (USD Billion)

Figure 10. Impact Analyses

Figure 11. Comparative Share Analysis of Veterinary Cro Market For Clinical Trials, By Country, 2018 & 2026 (%)

Figure 12. Comparative Share Analysis of Veterinary Cro Market For Toxicology, By Country, 2018 & 2026 (%)

Figure 13. Comparative Share Analysis of Veterinary Cro Market For Market Authorization And Regulatory Support Market, By Country, 2018 & 2026 (%)

Figure 14. Comparative Share Analysis of Veterinary Cro Market For Others, By Country, 2018 & 2026 (%)

Figure 15. Comparative Share Analysis of Veterinary Cro Market For Dogs, By Country, 2018 & 2026 (%)

Figure 16. Comparative Share Analysis of Veterinary Cro Market For Cats, By Country, 2018 & 2026 (%)

Figure 17. Comparative Share Analysis of Veterinary Cro Market For Others, By Country, 2018 & 2026 (%)

Figure 18. Comparative Share Analysis of Veterinary Cro Market For Oncology, By Country, 2018 & 2026 (%)

Figure 19. Comparative Share Analysis of Veterinary Cro Market For Infectious Disease, By Country, 2018 & 2026 (%)

Figure 20. Comparative Share Analysis of Veterinary Cro Market For Neurology, By Country, 2018 & 2026 (%)

Figure 21. Comparative Share Analysis of Veterinary Cro Market For Others, By Country, 2018 & 2026 (%)

Figure 22. U.S. Veterinary Cro Market, 2019-2026 (USD Million)

Figure 23. Canda Veterinary Cro Market, 2019-2026 (USD Million)

Figure 24. Mexico Veterinary Cro Market, 2019-2026 (USD Million)

Figure 25. Germany Veterinary Cro Market, 2019-2026 (USD Million)

Figure 26. France Veterinary Cro Market, 2019-2026 (USD Million)

Figure 27. Uk Veterinary Cro Market, 2019-2026 (USD Million)

Figure 28. Italy Veterinary Cro Market, 2019-2026 (USD Million)

Figure 29. Spain Veterinary Cro Market, 2019-2026 (USD Million)

Figure 30. Rest of Europe Veterinary Cro Market, 2019-2026 (USD Million)

Figure 31. Japan Veterinary Cro Market, 2019-2026 (USD Million)

Figure 32. China Veterinary Cro Market, 2019-2026 (USD Million)

Figure 33. Australia Veterinary Cro Market, 2019-2026 (USD Million)

Figure 34. Rest of Asia-Pacific Veterinary Cro Market, 2019-2026 (USD Million)

Figure 35. Brazil Veterinary Cro Market, 2019-2026 (USD Million)

Figure 36. South Africa Veterinary Cro Market, 2019-2026 (USD Million)

Figure 37. Saudi Arabia Veterinary Cro Market, 2019-2026 (USD Million)

Figure 38. Rest of Lamea Veterinary Cro Market, 2019-2026 (USD Million)

Figure 39. Market Player Positioning, 2018

Figure 40. Competitive Dashboard

Figure 41. Competitive Heatmap of Key Players

Figure 42. Charles River Laboratories Inc.: Net Sales, 2016-2018 (USD Million)

Figure 43. Charles River Laboratories Inc.: Revenue Share By Segments, 2018(%)

Figure 44. Charles River Laboratories Inc.: Revenue Share By Region, 2018 (%)

List Of Table

List of Tables

Table 01. North America And Europe Veterinary Cro Market, By Service Type, 2016-2026 (USD Million)

Table 02. Veterinary Cro Market For Clinical Trials, By Region, 2019-2026 (USD Million)

Table 03. Veterinary Cro Market For Toxicology Market, By Region, 2019-2026 (USD Million)

Table 04. Veterinary Cro Market For Market Authorization And Regulatory Support Market, By Region 2019-2026 (USD Million)

Table 05. Veterinary Cro Market For Others Market, By Region, 2019-2026 (USD Million)

Table 06. North America And Europe Veterinary Cro Market, By Animal Type, 2016-2026 (USD Million)

Table 07. Veterinary Cro Market For Dogs, By Region, 2019-2026 (USD Million)

Table 08. Veterinary Cro Market For Cats, By Region, 2019-2026 (USD Million)

Table 09. Veterinary Cro Market For Others, By Region, 2019-2026 (USD Million)

Table 10. North America And Europe Veterinary Cro Market, By Indication, 2016-2026 (USD Million)

Table 11. Veterinary Cro Market For Oncology, By Region, 2019-2026 (USD Million)

Table 12. Veterinary Cro Market For Infectious Disease Market, By Region, 2019-2026 (USD Million)

Table 13. Veterinary Cro Market For Neurology, By Region, 2019-2026 (USD Million)

Table 14. Veterinary Cro Market For Others, By Region 2019-2026 (USD Million)

Table 15. Veterinary Cro Market, By Region, 2018-2026 (USD Million)

Table 16. North America Veterinary Cro Market Revenue, By Country, 2019-2026 (USD Million)

Table 17. U.S. Veterinary Cro Market Revenue, By Service Type, 2019-2026 (USD Million)

Table 18. U.S. Veterinary Cro Market Revenue, By Animal Type, 2019-2026 (USD Million)

Table 19. U.S. Veterinary Cro Market Revenue, By Indication, 2019-2026 (USD Million)

Table 20. Canada Veterinary Cro Market Revenue, By Service Type, 2019-2026 (USD Million)

Table 21. Canada Veterinary Cro Market Revenue, By Animal Type, 2019-2026 (USD Million)

Table 22. Canada Veterinary Cro Market Revenue, By Indication, 2019-2026 (USD Million)

Table 23. Mexico Veterinary Cro Market Revenue, By Service Type, 2019-2026 (USD Million)

Table 24. Mexico Veterinary Cro Market Revenue, By Animal Type, 2019-2026 (USD Million)

Table 25. Mexico Veterinary Cro Market Revenue, By Indication, 2019-2026 (USD Million)

Table 26. North America Veterinary Cro Market Revenue, By Service Type, 2019-2026 (USD Million)

Table 27. North America Veterinary Cro Market Revenue, By Animal Type, 2019-2026 (USD Million)

Table 28. North America Veterinary Cro Market Revenue, By Indication, 2019-2026 (USD Million)

Table 29. Europe Veterinary Cro Market Revenue, By Country, 2019-2026 (USD Million)

Table 30. Germany Veterinary Cro Market Revenue, By Service Type, 2019-2026 (USD Million)

Table 31. Germany Veterinary Cro Market Revenue, By Animal Type, 2019-2026 (USD Million)

Table 32. Germany Veterinary Cro Market Revenue, By Indication, 2019-2026 (USD Million)

Table 33. France Veterinary Cro Market Revenue, By Service Type, 2019-2026 (USD Million)

Table 34. France Veterinary Cro Market Revenue, By Animal Type, 2019-2026 (USD Million)

Table 35. France Veterinary Cro Market Revenue, By Indication, 2019-2026 (USD Million)

Table 36. Uk Veterinary Cro Market Revenue, By Service Type, 2019-2026 (USD Million)

Table 37. Uk Veterinary Cro Market Revenue, By Animal Type, 2019-2026 (USD Million)

Table 38. Uk Veterinary Cro Market Revenue, By Indication, 2019-2026 (USD Million)

Table 39. Italy Veterinary Cro Market Revenue, By Service Type, 2019-2026 (USD Million)

Table 40. Italy Veterinary Cro Market Revenue, By Animal Type, 2019-2026 (USD Million)

Table 41. Italy Veterinary Cro Market Revenue, By Indication, 2019-2026 (USD Million)

Table 42. Spain Veterinary Cro Market Revenue, By Service Type, 2019-2026 (USD Million)

Table 43. Spain Veterinary Cro Market Revenue, By Animal Type, 2019-2026 (USD Million)

Table 44. Spain Veterinary Cro Market Revenue, By Indication, 2019-2026 (USD Million)

Table 45. Rest of Europe Veterinary Cro Market Revenue, By Service Type, 2019-2026 (USD Million)

Table 46. Rest of Europe Veterinary Cro Market Revenue, By Animal Type, 2019-2026 (USD Million)

Table 47. Rest of Europe Veterinary Cro Market Revenue, By Indication, 2019-2026 (USD Million)

Table 48. Europe Veterinary Cro Market Revenue, By Service Type, 2019-2026 (USD Million)

Table 49. Europe Veterinary Cro Market Revenue, By Animal Type, 2019-2026 (USD Million)

Table 50. Europe Veterinary Cro Market Revenue, By Indication, 2019-2026 (USD Million)

Table 51. Asia-Pacific Veterinary Cro Market Revenue, By Country, 2019-2026 (USD Million)

Table 52. Japan Veterinary Cro Market Revenue, By Service Type, 2019-2026 (USD Million)

Table 53. Japan Veterinary Cro Market Revenue, By Animal Type, 2019-2026 (USD Million)

Table 54. Japan Veterinary Cro Market Revenue, By Indication, 2019-2026 (USD Million)

Table 55. China Veterinary Cro Market Revenue, By Service Type, 2019-2026 (USD Million)

Table 56. China Veterinary Cro Market Revenue, By Animal Type, 2019-2026 (USD Million)

Table 57. China Veterinary Cro Market Revenue, By Indication, 2019-2026 (USD Million)

Table 58. Australia Veterinary Cro Market Revenue, By Service Type, 2019-2026 (USD Million)

Table 59. Australia Veterinary Cro Market Revenue, By Animal Type, 2019-2026 (USD Million)

Table 60. Australia Veterinary Cro Market Revenue, By Indication, 2019-2026 (USD Million)

Table 61. Rest of Asia-Pacific Veterinary Cro Market Revenue, By Service Type, 2019-2026 (USD Million)

Table 62. Rest of Asia-Pacific Veterinary Cro Market Revenue, By Animal Type, 2019-2026 (USD Million)

Table 63. Rest of Asia-Pacific Veterinary Cro Market Revenue, By Indication, 2019-2026 (USD Million)

Table 64. Asia-Pacific Veterinary Cro Market Revenue, By Service Type, 2019-2026 (USD Million)

Table 65. Asia-Pacific Veterinary Cro Market Revenue, By Animal Type, 2019-2026 (USD Million)

Table 66. Asia-Pacific Veterinary Cro Market Revenue, By Indication, 2019-2026 (USD Million)

Table 67. Lamea Veterinary Cro Market Revenue, By Country, 2019-2026 (USD Million)

Table 68. Brazil Veterinary Cro Market Revenue, By Service Type, 2019-2026 (USD Million)

Table 69. Brazil Veterinary Cro Market Revenue, By Animal Type, 2019-2026 (USD Million)

Table 70. Brazil Veterinary Cro Market Revenue, By Indication, 2019-2026 (USD Million)

Table 71. South Africa Veterinary Cro Market Revenue, By Service Type, 2019-2026 (USD Million)

Table 72. South Africa Veterinary Cro Market Revenue, By Animal Type, 2019-2026 (USD Million)

Table 73. South Africa Veterinary Cro Market Revenue, By Indication, 2019-2026 (USD Million)

Table 74. Saudi Arabia Veterinary Cro Market Revenue, By Service Type, 2019-2026 (USD Million)

Table 75. Saudi Arabia Veterinary Cro Market Revenue, By Animal Type, 2019-2026 (USD Million)

Table 76. Saudi Arabia Veterinary Cro Market Revenue, By Indication, 2019-2026 (USD Million)

Table 77. Rest of Lamea Veterinary Cro Market Revenue, By Service Type, 2019-2026 (USD Million)

Table 78. Rest of Lamea Veterinary Cro Market Revenue, By Animal Type, 2019-2026 (USD Million)

Table 79. Rest of Lamea Veterinary Cro Market Revenue, By Indication, 2019-2026 (USD Million)

Table 80. Lamea Veterinary Cro Market Revenue, By Service Type, 2019-2026 (USD Million)

Table 81. Lamea Veterinary Cro Market Revenue, By Animal Type, 2019-2026 (USD Million)

Table 82. Lamea Veterinary Cro Market Revenue, By Indication, 2019-2026 (USD Million)

Table 83. Charles River Laboratories, Inc.: Company Snapshot

Table 84. Charles River Laboratories, Inc.: Operating Segments

Table 85. Charles River Laboratories, Inc. Plc: Product Portfolio

Table 86. Clinvet: Company Snapshot

Table 87. Clinvet Inc.: Operating Segments

Table 88. Clinvet Inc.: Product Portfolio

Table 89. Klifovet Ag: Company Snapshot

Table 90. Klifovet Ag: Operating Segments

Table 91. Klifovet Ag: Product Portfolio:

Table 92. Lohlein & Wolf Vet Research: Company Snapshot

Table 93. Lohlein & Wolf Vet Research: Operating Segments

Table 94. Lohlein & Wolf Vet Research: Product Portfolio

Table 95. Oncovet Clinical Research: Company Snapshot

Table 96. Oncovet Clinical Research: Operating Segments

Table 97. Oncovet Clinical Research: Product Portfolio

Table 98. Ondax Scientific: Company Snapshot

Table 99. Ondax Scientific: Operating Segments

Table 100. Ondax Scientific: Product Portfolio

Table 101. Triveritas: Company Snapshot

Table 102. Triveritas: Operating Segments

Table 103. Triveritas: Product Portfolio

Table 104. (Vrm): Company Snapshot

Table 105. Vrm: Operating Segments

Table 106. Vrm: Product Portfolio

Table 107. Vetpharm, Inc.: Company Snapshot

Table 108. Vetpharm, Inc.: Product Segments

Table 109. Vetpharm, Inc.: Product Portfolio

Table 110. Vetspin Srl.: Company Snapshot

Table 111. Vetspin Srl.: Operating Segments

Table 112. Vetspin Srl: Product Portfolio

Licence Rights

Single-User license:

This grants one non-exclusive, non-transferable machine-readable license for the report either electronically or online. The right to store, display, use, or stockpile the report is restricted to only ONE authorized computer. For obtaining a single user license, ONLY an individual ("you") for individual use is entitled for using the product or as mentioned in the License Terms. Any individual representing an organization is refrained from accessing the products/services of AMR or as stated in the License Terms; any breach of which shall lead to violation of applicable laws in the United States, India, or in the jurisdiction of purchase. The products and services offered are the intellectual property of AMR, and are protected by applicable copyright laws, international treaty provisions, and other applicable laws of the country in which these are being used. Albeit the abovementioned, you are NOT be permitted to:

transmit or permit any third party to use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to assign the rights of the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use, or store the content from the report other than for internal business purposes; expressly permitted above; and

use the report in any comportment that would breach the terms and conditions contained in these License Terms or that would violate the applicable laws in the United Sates, India, or in any other jurisdiction.

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial/noncommercial gains

share the information or content either electronically or in printed form with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization or any other unauthorized users.

Five-User License:

This grants up to Five non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online. The right to store, transfer, display, use, or stockpile the report is restricted to only FIVE authorized users. An individual representing an organization or an organization shall ONLY purchase the five-user license. The authorized users can print additional duplicate printed copies of the report for distribution to the employees of his/her company (Personnel). Albeit the abovementioned, you are NOT be permitted to:

transmit or permit by any means to any third party (i.e. non-personnel) or unauthorized users for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer, or attempt to redistribute or assign rights of the report (in whole or in part) to any party NOT authorized by AMR;

take photocopies, share with non-authorized users, and/or copy content from this publication to further distribute for commercial or noncommercial gains.

share the information or content either electronically or as printed copies with fellow-mates, public libraries, researchers, lecturers, college, university, foundation, government agency, corporate, non-profit organization, or to more than 5 AUTHORIZED USERS.

Enterprise License:

This grants global, non-exclusive, non-transferable machine-readable licenses for using the report either electronically or online, within the organization and/or its subsidiaries. The authorized users shall have complete right to store, display, transfer, and/or use the report ONLY within the organization or its subsidiaries. Authorized users can take unlimited printed copies of the report for distribution among its employees. Albeit the abovementioned, you shall NOT be permitted to:

transmit or permit by any means to any third party (i.e. non-personnel) for use and/or gain access to the report;

resell, sub-license, rent, lease, transfer or attempt to assign the rights in the report (in whole or in part) to any party NOT authorized by AMR;

modify, alter, create database, broadcast, communicate, transfer, pledge, rent, reproduce, transmit, display, copy, distribute, commercially exploit, use or store the content from the report other than for internal business purposes; expressly permitted above; and

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Companies

Charles River Laboratories, Inc., Clinvet, KLIFOVET AG, Lohlein & Wolf Vet Research, Oncovet Clinical Research, ONDAX Scientific, Triveritas, Veterinary Research Management (VRM) Ltd, VetPharm, Inc., and VETSPIN SRL.

Company Profile

Company Profile Title

Single User Licence

USD 200

Corporate User Licence

USD 500